Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues.

Thanks to updated guidelines published in March, an additional 21.5 million adults between the ages of 30 and 79 are now eligible for statins. Researchers did emphasize that lifestyle changes are another effective way to reduce ASCVD risk. 

Flu vaccines were also associated with lower rates of all-cause mortality, myocardial infarction and heart failure, researchers noted. 

Novo Nordisk filed a lawsuit claiming Eli Lilly ran “false and materially misleading” advertisements that ignore recent data. According to Lilly, though, its message is "truthful" and "grounded in the most direct scientific evidence available."

There has been progress over the years, researchers noted, but there is still a lot of work to do. 

Ami B. Bhatt, MD, a veteran cardiologist and digital health specialist, stepped down as the American College of Cardiology's chief innovation officer to accept this new role. 

Data on the potential relationship between cannabis use and CVD remain mixed. For now, however, there is enough evidence available that heart patients should be careful. 

Enlicitide, the new oral PCSK9 inhibitor from Merck, will be sold under the brand name Lipfendra. It is approved to reduce LDL-C in patients with hypercholesterolemia, including HeFH.

When patients take semaglutide, you can't necessarily predict the cardiovascular impact by tracking weight loss. A lot of it appears to comes down to the dose. 

The long-lasting implant could help patients benefit from semaglutide therapy without needing to take the drug on a daily basis.